Breast Cancer Clinical Trials in Pittsburgh

Showing 321-340 of 363 trials

Safety Study of Modified Vaccinia Virus to Cancer

NCT00574977

The purpose of this study is to determine the safety and maximum tolerated dose from injecting this vaccinia virus into tumors or infusion.

MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more

David Bartlett26 participantsStarted May 2008

Pittsburgh, Pennsylvania, United States

COMPLETEDPHASE3< 1 mile

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

NCT00003162

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases. PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases from breast or prostate cancer.

Breast CancerMetastatic CancerPain+1 more

Radiation Therapy Oncology Group949 participantsStarted Feb 1998

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Huntsville, Alabama, United States +250 more locations

Safety Study of Modified Vaccinia Virus to Cancer

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Breast Cancer Trials in Other Cities

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Couple-Focused Intervention for Breast Cancer Patients

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)

Other Conditions in Pittsburgh